Anant Labs

Brinzolamide

CAS 138890-62-7

Overview

Brinzolamide is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Brinzolamide was approved as a generic medication in the United States in November 2020

Anant Labs manufacture and furnish high quality Brinzolamide impurities for global markets. Our Brinzolamide EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Brinzolamide
In Stock

Brinzolamide

CAS 138890-62-7In Stock
WhatsApp
Technical Data
CAS138890-62-7
Mol. FormulaC12H21N3O5S3
Mol. Weight383.517 g/mol
IUPAC(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide
SMILESCCN[C@H]1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
InChIInChI=1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1
InChI KeyHCRKCZRJWPKOAR-JTQLQIEISA-N

Note: We are upgrading our system, Cat No will change.

Synonyms
Brinzolamide138890-62-7AzoptAL-4862BrinzolamidaAL 4862DTXSID6045531NSC-760050CHEBI:3176(R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide 1,1-dioxide

Looking for a specific reference standard?

Tell us what you need. Our team responds within one business day.